Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous/Extended vs Intermittent Betalactam Infusion in Pediatric Sepsis
NCT03019965Completed
- Sponsor
- Coordinación de Investigación en Salud
- Start
- Feb 2017
- Primary completion
- Dec 2019
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised trial of piperacillin + tazobactam, imipenem and meropenem in sepsis (6 arms), sponsored by Coordinación de Investigación en Salud. Primary endpoint: Number of Participants With Clinical Response at 28 days. Started Feb 2017; status: completed.
02
Drugs
piperacillin + tazobactamimipenemmeropenem
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03019965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03019965.